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Purpose or Objective: Prognostic factors in early stage 
resected oral squamous cell cancers (OSCC) are not well 
understood. The aim of this audit was to identify factors 
influencing recurrence in pT1-2N0M0 patients with a view to 
determine the role and indications for adjuvant radiotherapy 
(adjRT). 
 
Material and Methods: Between Aug 2011 to May 2014, 120 
patients were determined to have pT-2N0M0 disease 
following histopathological examination after primary surgery 
for oral cancer. Primary sites included oral tongue (66, 55%), 
buccal mucosa (31, 26%), gingiva (10, 8%), retromolar trigone 
(9, 7%) and lip (4, 3%). AdjRT was advised to 46 (38%) 
patients on an individual basis in a multidisciplinary meeting, 
determined by the presence of one or a combination of 
known risk factors. Patients with close or positive margins 
always received chemoradiation. AdjRT was delivered with 
3D conformal or intensity modulated techniques to a dose of 
60Gy/30Fr/6weeks to the tumor bed and 54-
60Gy/30Fr/6weeks to the resected but uninvolved nodal 
levels. Disease –related outcomes were calculated, and 
pathological prognostic factors were assessed using univariate 
and multivariate analyses. The impact of adjRT in reducing 
disease recurrence was assessed. 
 
Results: The median age was 55 (25-82) years. The median 
tumor size was 2.2 cm. The median depth of infiltration was 
6mm. The incidence of known pathological prognostic factors 
is listed in Table 1. The median follow up was 23 months (2-
44 months). A total of 13 patients had recurrence (local 8; 
nodal 4, distant 3, including overlapping failures). All 
locoregional failures were within the RT volumes. The 2yr 
and 3 year disease-free-survival (DFS) was 89% and 82% 
respectively. On univariate analysis pT2 tumors, 
lymphovascular invasion (LVI), perineural invasion (PNI) and 
depth of invasion >=5mm were statistically significant 
prognosticators for DFS (Table 1). Primaries of the oral 
tongue showed a trend towards shorter DFS. None of these 
factors were independently prognostic on multivariate 
analysis. A scoring system using the number of risk-factors 
was created. Patients were grouped as Low risk (0-1 factor); 
Intermediate risk (2-3 factors) and High-risk (4-7 factors). 
There was significant difference in DFS of patients in 
different risk groups (Fig 1). RT was considered unnecessary 
in Low risk patients (none of 39 received RT, 3 yr DFS 97.1%). 
In High risk patients, prognosis was poor despite RT (22/25 
received RT, 3 yr DFS 68.5%). In the Intermediate risk group, 
24/54 patients received RT, but this made no difference to 
the risk of disease recurrence (2 local failures each in RT vs. 
no RT cohorts, 3 yr DFS 85.1% vs 72.1%, p=0.75). 
 
 
 
 
 
 
Conclusion: Several pathological risk factors alone and in 
combination impact disease related outcomes even in pT1-
2N0 OSCC. Standard AdjRT did not have a clear effect on 
reducing recurrence in our cohort in patients with up to 3 risk 
factors. 
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Purpose or Objective: To investigate clinical and volumetric 
prognostic factors in head and neck cancer (HNC) patients 
(pts) treated with curative external beam radiation therapy 
(EBRT). 
 
Material and Methods: Sixty-four oropharyngeal squamous 
cell carcinoma (OSCC) pts and 79 hypopharyngeal squamous 
cell carcinoma (HSCC) pts treated with curative EBRT were 
enrolled in this retrospective analysis. No pt had previously 
undergone surgery for HNC. The median total EBRT dose was 
70 Gy (range, 60–72 Gy). For planning EBRT, computed 
tomography (CT) images were acquired prior to EBRT 
initiation and at 3–5 weeks after the initiation of EBRT for 
replanning in each pt. We assessed the gross tumor volume 
(GTV) reduction rate (GTVRR) on the basis of the results from 
the initial and replanning CT images. Initial cervical body 
volume (CBV) was measured from the initial CT images. For 
induction chemotherapy (IC), seven pts received docetaxel 
(DOC), cisplatin (CDDP), and 5-fluorouracil (5-FU) (TPF 
regimen). One course of CDDP plus 5-FU and two courses of 
TPF regimen were delivered to one pt. In total, 125 pts 
(87.4%) received concurrent chemotherapy (CC) using the 
following regimen: TPF in 55 (38.5%) pts; another CDDP-based 
regimen in 43 (30.1%) pts; another DOC-based regimen in 22 
(15.4%) pts; cetuximab in 3 (2.0%) pts; nedaplatin and 5-FU in 
1 (0.7%) pt; and S-1 (tegafur, gimeracil, and oteracil) in 1 
(0.7%) pt. The disease stage was I in 5 (3.5%) pts, II in 20 
(14%) pts, III in 24 (16.8%) pts, and IV in 93 (65%) pts. 
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Progression-free survival (PFS) and overall survival (OS) were 
estimated by the Kaplan–Meier method. Cox regression was 
performed to explore parameters in association with PFS and 
OS. The potential variables that were examined included age; 
gender; primary site; UICC stages; serum albumin, C-reactive 
protein (CRP), albumin–globulin ratio, body weight (BW) and 
body mass index prior to treatment; initial CBV and GTV; 
GTVRR during EBRT; IC; and CC. 
 
Results: The median follow-up period was 23 months (range, 
2–95 months). The 2-year PFS and OS rates were 51.3% [95% 
confidence interval (CI), 40.2–55.7] and 71.0% (95% CI, 58.4–
72.6), respectively. PFS was associated with age [hazard ratio 
(HR): 1.029 (95% CI, 1.001–1.058), p = 0.04]; stage IV disease 
[HR: 3.755 (95% CI, 1.810–7.788), p < 0.001]; pretreatment 
CRP [HR: 1.077 (95% CI, 1.008–1.152) p = 0.029]; initial GTV 
[HR: 1.004 (95% CI, 1.000–1.007), p = 0.026]; and GTVRR 
during EBRT [HR: 0.99 (95% CI, 0.982–0.998), p = 0.016]. OS 
was related to stage IV disease [HR: 3.669 (95% CI, 1.667–
8.071), p = 0.001]; GTVRR during EBRT [HR: 0.986 (95% CI, 
0.975–0.997), p = 0.012]; and pretreatment BW [HR: 0.927 
(95% CI, 0.892–0.963), p < 0.001]. 
 
Conclusion: This study suggested the prognostic value of 
clinical and volumetric status. Clinical stage, age, 
pretreatment CRP and BW, initial GTV, and shrinkage of GTV 
during treatment appear to be critical in the HNC treatment 
strategy. 
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Purpose or Objective: Head and neck cancer patients 
suffered from swallowing and speaking difficulties, neck pain 
and stiffness, and cosmetic disfigurement, resulting in 
interpersonal relationship troubles and social and emotional 
adaptation issues. Discussing cancer and the quality of 
communication when facing stress would affect partner’s 
adaptation to cancer and quality of relationship. This study 
investigated the (Cancer-related) communication pattern, 
effect of disease characteristics in head and neck cancer. We 
used dyadic analysis to investigate the impact and process of 
communication pattern on quality of relationship. 
 
Material and Methods: This study is cross-sectional design, 
and subject were the male patients who completion of 
cancer treatment more than 3 months and their partners with 
head and neck cancer, included 131 patient-partner dyads. 
Each participant completed the basic information 
questionnaire, Communication Pattern Questionnaire, Dyadic 
and Adjustment Scale. 
 
Results: By treatment, there are no difference on cancer-
related communication pattern for both patient and partner. 
Both patient and partner, their perception of mutual 
constructive communication was associated with more 
quality of relationship, Demand-withdraw communication and 
mutual avoidancewas associated with less quality of 
relationship. Using the Actor-Partner interdependence model 
(APIM), result reveled that although each person’s cancer-
related communication pattern is the strongest predictor of 
their own quality of relationship, partner’s perception of 
communication pattern also play significant role on patient’s 
quality of relationship. According to APIM, only the partner 
perceived communication pattern could be accounted for by 
their influence on quality of relationship. 
 
Conclusion: We found that cancer-related communication 
and interaction of relationship among couples play an 
important role in the head and neck adjustment process. 
Thus, except the medical care, clinicians concern with 
interaction between patient and partner can be enhance 
their psychological adjustment and illness, particularly the 
partner’s perception of communication pattern, which may 
improve the quality of relationship and life adaptation of 
both couples when they are dealing with head and neck 
cancer. 
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Purpose or Objective: Reducing overall treatment time has 
advantages for patient convenience, but also for local control 
as shown by former studies. Critical organs in the neck causes 
concern in relation to long-term morbidity and quality of life, 
but with recent advances with high-precision image-guided 
and intensity-modulated radiotherapy (IMRT) techniques, 
avoidance of the organs at risk has become possible. The 
purpose of this study is to develop an image-guided high-dose 
hypofractionated vocal cord irradiation technique to treat 
patients with early stage glottic cancer. 
 
Material and Methods: Eligible patients with early stage 
glottic cancer provided with informed consent will receive 
hypofrationated radiotherapy to the larynx with a 
simultaneous boost to the gross tumor. The fraction size will 
be stepwise increased from 3.5Gy (total dose 59.4Gy) to 9Gy 
(total dose 45Gy). To proceed to the next dose level, at least 
7 patients should be confirmed that they have no toxicity 
more than grade 2 after 3 month post-RT. The organs at risk 
include the larynx, contralateral vocal cord, arytenoids, 
carotid arteries, inferior pharyngeal constrictor muscle, and 
spinal cord. 
 
Results: Four patients were enrolled to receive 59.4Gy with 
3.5Gy per fraction until July 2015. None of the patients 
developed toxicity more than grade 2 after 1 month post-RT. 
The mean equivalent dose in 2Gy fractions (EQD2) to 
contralateral arytenoid, thyroid gland, inferior pharyngeal 
constrictor muscle, and larynx were in average 69.5Gy, 
12.3Gy, 50.8Gy, and 66.5Gy, respectively. No portion of the 
carotid arteries were irradiated more than 50 Gy (EQD2) in 
the IMRT plan. After 3 months of follow-up, all 4 patients 
demonstrated no more than grade 3 toxicities. Also, all 
patients showed complete remission by laryngoscopy. 
 
Conclusion: The high-dose hypofractionated IMRT technique 
provided good sparing of critical structures and resulted in no 
severe toxicity after a short term follow up. We will 
continuously perform this phase I clinical trial to stepwise 
increase the fraction size up to 9Gy. 
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Purpose or Objective: 
Objective: The aim of this study was to investigate the 
feasibility of high dose-low energy intraoperative radiation 
(IORT) therapy using INTRABEAM© (Carl Zeiss Surgical, 
Oberkochen, Germany) in the treatment of malignant Head & 
Neck tumors.  
 
Methods and Materials: Between March 2014 and July 2015, 
12 patients with head and neck cancers (seven with primary 
malignant parotid tumors and five patients with previously 
treated recurrent head and neck cancer) received 
intraoperative radiation therapy after surgical resection at 
Loyola University Medical Center (Maywood, IL). The median 
dose prescription was 6Gy (range, 5-14Gy) prescribed to 5mm 
